USE OF LEPTINE FOR THE TREATMENT OF HUMAN LIPOATROPHY AND METHOD TO DETERMINE THE PREDISPOSITION TO THIS TREATMENT.

摘要

A method for determining the predisposition of a lipoatrophic patient to respond to treatment with a leptin protein, and the method comprises: (a) determining the level of leptin in the patient prior to said treatment; (b) determine if the leptin level is less than or equal to approximately 4 ng / ml; and (c) assign a predisposition to said patient to respond to a replacement therapy comprising said treatment with said leptin protein.